期刊文献+

美罗培南联合万古霉素双途径给药治疗开颅术后颅内感染应用效果 被引量:19

Effect of meropenem combined vancomycin on treating intracranial infection after craniotomy
暂未订购
导出
摘要 目的探讨美罗培南、万古霉素静脉滴注联合万古霉素鞘内给药治疗开颅术后颅内感染的应用效果。方法选取延安大学附属医院自2015年7月至2016年6月收治的63例开颅手术术后感染的患者,随机分为A组(n=31)和B组(n=32)。A组采用常规静脉滴注美罗培南和万古霉素进行治疗;B组在A组的基础上予以每日10 mg的万古霉素鞘内给药。比较两组的临床疗效,并分析治疗前、后的颅内压、脑脊液常规和血清炎性因子水平。结果 B组总疗程短于A组,痊愈率和有效率均高于A组,差异有统计学意义(P<0.05)。治疗后,两组脑脊液葡萄糖、蛋白质及pH水平变化不大,两组比较,差异无统计学意义(P>0.05);但两组颅内压和白细胞计数有降低,且B组低于A组,两组比较,差异有统计学意义(P<0.05)。治疗后,两组患者血清C反应蛋白、白细胞介素-6及肿瘤坏死因子α水平有所降低,且B组低于A组,两组比较,差异有统计学意义(P<0.05)。结论美罗培南、万古霉素静脉滴注联合10 mg万古霉素鞘内给药治疗颅内感染疗效明确,安全性高,具有一定的临床推广价值。 Objective To investigate the effect of intravenous meropenem combined intratheeal vancomycin on treating intracranial infection after craniotomy. Methods A retrospective study was performed on 63 cases of patients with intracranial infection after craniotomy who were admitted from July 2015 to June 2016. Patients were randomly divided into Group A( n = 31 )and Group B (n = 32). Patients in Group A were given conventional intravenous meropenem combined vaneomyein ;the others in Group B were given 10 mg intrathecal vancomycin on the base of method in Group A. The intracranial pressure, cerebrospinal fluid routine examination and serum inflammatory cytokines were analyzed before and after the treatment. Results The total course of Group B was shorter than that of Group A (P 〈 0. 05 ). After the treatment, the glucose, protein and pH levels of cerebrospinal fluid were changed little, and there was no statistically significant difference between the two groups (P 〉 0. 05 ) ;the intracranial pressure and eerebrospinal fluid hemameba levels reduced, and the level of Group B was lower than that of Group A( P 〉 0. 05 ). After the treatment, the serum levels of CRP, IL-6 and TNF-α were all reduced, and the level of Group B was lower than that of Group A ( P 〈 0.05 ). Conclusion Intravenous meropenem combining intrathecal vancomycin (10 mg)has a certain effect and security to treat intracranial infection after craniotomy, which is worth of clinical promotion.
出处 《临床军医杂志》 CAS 2017年第8期820-823,共4页 Clinical Journal of Medical Officers
关键词 美罗培南 万古霉素 鞘内给药 颅内感染 Meropenem Vancomycin Intrathecal drug delivery Intracranial infection
  • 相关文献

参考文献10

二级参考文献96

  • 1邓晰明,樊俊红,汪华学,赵飞,邹琪.老年重症感染患者应用万古霉素的疗效及安全性[J].中国老年学杂志,2015,35(2):311-312. 被引量:4
  • 2周忠清,郑今兰,张劲松,刘荣,石祥恩.开颅术后颅内感染的诊断与治疗[J].中华医院感染学杂志,2005,15(4):402-404. 被引量:47
  • 3周建新,王强,唐明忠,赵继宗.神经外科患者脑脊液细菌流行病学和耐药性监测[J].中华医院感染学杂志,2006,16(2):154-157. 被引量:51
  • 4靳桂明,董玉梅,余爱荣,张瞿璐.开颅手术后颅内感染流行病学调查的荟萃分析[J].中国临床神经外科杂志,2007,12(3):149-151. 被引量:92
  • 5EMEA. Note for guidance on evaluation of medicinal products indicated for treatment of bacterial infections[ EB/OL]. http://www. emea. europa. eu/pdfs/human/ewp/055895en: pdf. ,2004 - 04 - 22.
  • 6中华人民共和国卫生部药政局.抗菌药物临床研究指导原则.新药(西药)临床研究指导原则汇编.1993年7月.
  • 7FDA. Guidance For Industry. Developing antimicrobial drugs - general considerations for clinical, trial [EB/OL]. http://www.fda. gov, 1998-07.
  • 8FDA. Guidance For Industry. Evaluating clinical studies of antimicrobials in the division of anti - infective drugs products [EB/OL]. http://www. fda. gov,1997 -02 - 18.
  • 9MHLW.抗菌藥臨床評価のガイドライン[EB/OL].http://www.mhlw.go.jp,1998-08-25.
  • 10王忠诚.神经外科学[M].武汉:湖北科学技术出版社,2004.483-486.

共引文献134

同被引文献104

引证文献19

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部